SO
MRNA icon

STRS Ohio’s Moderna MRNA Stock Holding History

STRS Ohio’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Buy
209,874
+132,403
+171% +$6.85M 0.06% 327
2026
Q1 		$3.94M Buy
77,471
+68,887
+803% +$3.21M 0.02% 505
2025
Q4 		$253K Buy
8,584
+102
+1% +$2.77K ﹤0.01% 1416
2025
Q3 		$219K Buy
8,482
+4
+0% +$112 ﹤0.01% 1487
2025
Q2 		$234K Sell
8,478
-63,802
-88% -$1.68M ﹤0.01% 1613
2025
Q1 		$2.05M Sell
72,280
-850
-1% -$30.2K 0.01% 599
2024
Q4 		$3.04M Sell
73,130
-4,375
-6% -$209K 0.01% 545
2024
Q3 		$5.18M Sell
77,505
-7,610
-9% -$699K 0.02% 482
2024
Q2 		$10.1M Buy
85,115
+1,450
+2% +$183K 0.04% 365
2024
Q1 		$8.91M Sell
83,665
-5,440
-6% -$548K 0.04% 393
2023
Q4 		$8.86M Sell
89,105
-3,689
-4% -$310K 0.04% 378
2023
Q3 		$9.58M Sell
92,794
-3,053
-3% -$341K 0.04% 366
2023
Q2 		$11.6M Sell
95,847
-11,425
-11% -$1.52M 0.05% 348
2023
Q1 		$16.5M Buy
107,272
+2,611
+2% +$431K 0.07% 295
2022
Q4 		$18.8M Sell
104,661
-1,147
-1% -$188K 0.08% 278
2022
Q3 		$12.5M Sell
105,808
-1,604
-1% -$243K 0.06% 328
2022
Q2 		$15.3M Sell
107,412
-2,673
-2% -$382K 0.07% 304
2022
Q1 		$19M Buy
110,085
+4,492
+4% +$756K 0.07% 302
2021
Q4 		$26.8M Sell
105,593
-26,959
-20% -$7.88M 0.09% 253
2021
Q3 		$51M Sell
132,552
-24,127
-15% -$8.9M 0.19% 128
2021
Q2 		$36.8M Buy
156,679
+146,137
+1,386% +$26.1M 0.13% 186
2021
Q1 		$1.38M Buy
10,542
+741
+8% +$107K 0.01% 939
2020
Q4 		$1.02M Sell
9,801
-1,946
-17% -$197K ﹤0.01% 1040
2020
Q3 		$831K Buy
11,747
+1,470
+14% +$102K ﹤0.01% 1029
2020
Q2 		$659K Buy
+10,277
New +$563K ﹤0.01% 1107

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

STRS Ohio's MRNA Position: Q2 2026 in Review

STRS Ohio increased its Moderna (MRNA) stake by 171% in Q2 2026, buying an estimated $6.85M and bringing the position to 209,874 shares worth $14.7M. The position accounts for 0.06% of the portfolio, ranked #327.

STRS Ohio first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $51M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • STRS Ohio held 209,874 shares of Moderna worth $14.7M as of Q2 2026.
  • STRS Ohio bought 132,403 Moderna shares in Q2 2026, an estimated $6.85M.
  • Moderna made up 0.06% of STRS Ohio's portfolio in Q2 2026, its #327 holding.
  • STRS Ohio first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • STRS Ohio's Moderna position peaked at $51M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.